Author | Claudine Isaacs, MD | OncLive

Author | Claudine Isaacs, MD

Articles

Dr. Isaacs Discusses Antibody Drug Conjugates in TNBC

March 01, 2018

Claudine Isaacs, MD, professor, medical director, Fisher Center for Familial Cancer Research, co-director, Breast Cancer Program, Georgetown University/Lombardi Cancer Center, discusses antibody drug conjugates in the treatment of patients with triple-negative breast cancer.

Dr. Isaacs Discusses the Future of Treatment for HER2+ Breast Cancer

February 14, 2018

Claudine Isaacs, MD, professor, medical director, Fisher Center for Familial Cancer Research, co-director, Breast Cancer Program, Georgetown University/Lombardi Cancer Center, discusses the future of treatment for patients with HER2-positive breast cancer.

Dr. Isaacs Discusses Sacituzumab Govitecan in TNBC

February 05, 2018

Claudine Isaacs, MD, professor, medical director, Fisher Center for Familial Cancer Research, co-director, Breast Cancer Program, Georgetown University/Lombardi Cancer Center, discusses sacituzumab govitecan (IMMU-132) for the treatment of patients with triple-negative breast cancer.

Dr. Isaacs Discusses the Role of Neratinib in HER2+ Breast Cancer

January 26, 2018

Claudine Isaacs, MD, professor, medical director, Fisher Center for Familial Cancer Research, co-director, Breast Cancer Program, Georgetown University/Lombardi Cancer Center, discusses the role of neratinib (Nerlynx) in the treatment landscape of HER2-positive breast cancer.

x